Medicare Policy Changes
Expert articles and analysis related to medicare policy changes.
AI Summary — Last 7 Days
CMS’s Medicare value-based agenda is showing a split-screen dynamic: CMMI is continuing model implementation and refinement under the Trump administration—e.g., ACCESS resources for specialists and ongoing attention to GUIDE, LEAD, and CJR-X—while stakeholders are questioning how much fee-for-service–anchored models can truly shift risk, attribution, and care redesign incentives. At the same time, Medicare Advantage remains volatile: another CMS star ratings recalculation is reshaping bonus-payment expectations for plans such as Humana and Clover, while RADV extrapolation risk is intensifying plan scrutiny of coding, documentation, and reserve strategy (STAT on MA star recalculations; Wakely on RADV extrapolation). For ACOs, provider groups, and payers, the week’s pattern is clear: CMS is preserving VBC infrastructure, but financial predictability—especially in MA quality bonuses, audits, and model design—remains a central strategic risk.
Related Articles
STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end
After July 1, Medicare will offer GLP-1 weight-loss drugs for $50. It's supposed to be temporary, but chances are it won't be.
STAT+: CMS recalculates Medicare Advantage star ratings again, adding more volatility to program
Medicare Advantage plans that receive four out of five stars or better get bonus payments, which have ballooned to $16 billion this year.
What Upstream Prior Authorization Denials Mean for Home Health Providers
Changes in Medication Use After Medicare Part D Annual Out-of-Pocket Spending Caps
Changes in Medication Use After Medicare Part D Annual Out-of-Pocket Spending Caps JAMA
Changes in Medication Use After Medicare Part D Annual Out-of-Pocket Spending Caps
Changes in Medication Use After Medicare Part D Annual Out-of-Pocket Spending Caps JAMA
Drivers of Growth in Federal Spending on Medicare, 2000 to 2024 - Congressional Budget Office (.gov)
Drivers of Growth in Federal Spending on Medicare, 2000 to 2024 Congressional Budget Office (.gov)
OIG Publishes Medicare Advantage Industry-Specific Guidance
OIG Publishes Medicare Advantage Industry-Specific Guidance JD Supra
MedPAC to Congress: Here’s how to rework Medicare’s misaligned incentives
MedPAC to Congress: Here’s how to rework Medicare’s misaligned incentives Medical Economics
MedPAC to Congress: Here’s how to rework Medicare’s misaligned incentives
What CMS’s hospice and home health Medicare freeze means for the industry
The Trump administration has paused new enrollment in the areas for six months.